attached imageattached imageattached imageattached image

 

On January 21, KyungDong Pharm met at EL Tower in Yangjae-dong, Seoul, to review its 2025 performance and discuss its 2026 business plans, followed by the 2025 Outstanding Employee Awards. CEOs Ryu Ki-sung and Kim Kyung-hoon, division heads, senior team leaders and team leaders attended presentations on the year’s results and detailed plans for 2026. The sixth annual awards recognized employees with outstanding capabilities who had made major contributions to the company in 2025. Purple-level awards went to Park Se-eun of Validation and Solid Dosage Form Team 2. Green-level awards went to Yoon So-hee of the Patent and Clinical Affairs Team, Lee Se-young of the Pharmacovigilance and Medical Affairs Team, and Jung Su-bin of the IT Team.